Clinical Trial: A Study of SI-B036 in Patients With Locally Advanced or Metastatic Solid Tumors

U.S., May 27 -- ClinicalTrials.gov registry received information related to the study (NCT07606612) titled 'A Study of SI-B036 in Patients With Locally Advanced or Metastatic Solid Tumors' on May 19.

Brief Summary: This study is an open-label, multicenter, non-randomized Phase I clinical study of dose-escalation and expansion to evaluate the safety, tolerability, pharmacokinetic characteristics and preliminary efficacy of SI-B036 bispecific antibody injection in patients with locally advanced or metastatic solid tumors.

Study Start Date: May, 2026

Study Type: INTERVENTIONAL

Condition: Solid Tumor

Intervention: DRUG: SI-B036

Administration by intravenous infusion for a cycle of 3 weeks.

Recruitment Status: NOT_YET_RECRUITING

Sponso...